4.8 Article

Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24

期刊

NATURE COMMUNICATIONS
卷 10, 期 -, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41467-019-12384-2

关键词

-

资金

  1. National Key RAMP
  2. D Program of China [2018YFA0902700, 2018YFA0107201]
  3. Strategic Priority Research Program of the Chinese Academy of Sciences [XDPB10, XDB19000000]
  4. Key Research Program of the Chinese Academy of Sciences (CAS) [KFZD-SW-216]
  5. National Natural Science Foundation of China [81571545, 81770567, 81825018]
  6. Jiangsu Provincial Key and Development Program [BE2016722]
  7. Thousand Young Talents Plan of China
  8. CAS Key Laboratory of Tissue Microenvironment and Tumor

向作者/读者索取更多资源

Stat6 is known to drive macrophage M2 polarization. However, how macrophage polarization is fine-tuned by Stat6 is poorly understood. Here, we find that Lys383 of Stat6 is acetylated by the acetyltransferase CREB-binding protein (CBP) during macrophage activation to suppress macrophage M2 polarization. Mechanistically, Trim24, a CBP-associated E3 ligase, promotes Stat6 acetylation by catalyzing CBP ubiquitination at Lys119 to facilitate the recruitment of CBP to Stat6. Loss of Trim24 inhibits Stat6 acetylation and thus promotes M2 polarization in both mouse and human macrophages, potentially compromising antitumor immune responses. By contrast, Stat6 mediates the suppression of TRIM24 expression in M2 macrophages to contribute to the induction of an immunosuppressive tumor niche. Taken together, our findings establish Stat6 acetylation as an essential negative regulatory mechanism that curtails macrophage M2 polarization.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

TRIM24 facilitates antiviral immunity through mediating K63-linked TRAF3 ubiquitination

Qingchen Zhu, Tao Yu, Shucheng Gan, Yan Wang, Yifei Pei, Qifan Zhao, Siyu Pei, Shumeng Hao, Jia Yuan, Jing Xu, Fajian Hou, Xuefeng Wu, Chao Peng, Ping Wu, Jun Qin, Yichuan Xiao

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Article Multidisciplinary Sciences

Small-molecule inhibitor targeting orphan nuclear receptor COUP-TFII for prostate cancer treatment

Leiming Wang, Chiang-Min Cheng, Jun Qin, Mafei Xu, Chung-Yang Kao, Jingjing Shi, Erli You, Wanchun Gong, Laura Pedro Rosa, Peter Chase, Louis Scampavia, Franck Madoux, Timothy Spicer, Peter Hodder, H. Eric Xu, Sophia Y. Tsai, Ming-Jer Tsai

SCIENCE ADVANCES (2020)

Article Oncology

SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways

Huairui Yuan, Ying Han, Xuege Wang, Ni Li, Qiuli Liu, Yuye Yin, Hanling Wang, Lulu Pan, Li Li, Kun Song, Tong Qiu, Qiang Pan, Qilong Chen, Guoying Zhang, Yi Zang, Minjia Tan, Jian Zhang, Qintong Li, Xiaoming Wang, Jun Jiang, Jun Qin

CANCER CELL (2020)

Article Immunology

Brg1 restrains the pro-inflammatory properties of ILC3s and modulates intestinal immunity

Xinyi Qi, Jinxin Qiu, Jiali Chang, Yan Ji, Qi Yang, Guoliang Cui, Liming Sun, Qian Chai, Jun Qin, Ju Qiu

Summary: Brg1 plays a critical role in the differentiation of NKp46(+) ILC3s by promoting T-bet expression in NKp46(-) ILC3s, facilitating the conversion of NKp46(-) ILC3s into NKp46(+) ILC3s, and ultimately restraining intestinal inflammation. Our study demonstrates that Brg1 enhances T-bet and inhibits GM-CSF expression in ILC3s through a cell-intrinsic manner, highlighting its essential role in regulating intestinal immunity.

MUCOSAL IMMUNOLOGY (2021)

Article Oncology

Histone demethylase PHF8 drives neuroendocrine prostate cancer progression by epigenetically upregulating FOXA2

Qiuli Liu, Jian Pang, Lin-ang Wang, Zhuowei Huang, Jing Xu, Xingxia Yang, Qiubo Xie, Yiqiang Huang, Tang Tang, Dali Tong, Gaolei Liu, Luofu Wang, Dianzheng Zhang, Qiang Ma, Hualiang Xiao, Weihua Lan, Jun Qin, Jun Jiang

Summary: The study demonstrates that PHF8 is essential for the development of NEPC by transcriptionally upregulating the FOXA2 gene, which regulates the expression of genes involved in NEPC development. Both PHF8 and FOXA2 could potentially serve as biomarkers for NEPC and targeting them may be a therapeutic strategy for NEPC treatment.

JOURNAL OF PATHOLOGY (2021)

Article Biochemistry & Molecular Biology

Peli1 impairs microglial Aβ phagocytosis through promoting C/EBPβ degradation

Jing Xu, Tao Yu, Enrica Caterina Pietronigro, Jia Yuan, Jessica Arioli, Yifei Pei, Xuan Luo, Jialin Ye, Gabriela Constantin, Chaoming Mao, Yichuan Xiao

PLOS BIOLOGY (2020)

Article Immunology

The ubiquitin ligase Peli1 inhibits ICOS and thereby Tfh-mediated immunity

Xinfang Huang, Shumeng Hao, Junli Liu, Yuanyuan Huang, Manman Liu, Chunyuan Xiao, Yan Wang, Siyu Pei, Tao Yu, Jing Xu, Haikun Wang, Dongfang Dai, Xiao Su, Yichuan Xiao

Summary: Peli1 is identified as a critical negative regulator of Tfh cell differentiation, promoting autoimmune diseases while protecting against H1N1 influenza virus infection. Targeting Peli1 may have therapeutic benefits for Tfh-related autoimmune or infectious diseases.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Article Immunology

Cytoplasmic DNA sensing by KU complex in aged CD4+ T cell potentiates T cell activation and aging-related autoimmune inflammation

Yan Wang, Zunyun Fu, Xutong Li, Yinming Liang, Siyu Pei, Shumeng Hao, Qingchen Zhu, Tao Yu, Yifei Pei, Jia Yuan, Jialin Ye, Jiemeng Fu, Jing Xu, Jin Hong, Ruirui Yang, Hui Hou, Xinfang Huang, Chao Peng, Mingyue Zheng, Yichuan Xiao

Summary: The study reveals that the KU complex is abundantly expressed in CD4(+) T cells and enhances cell activation and proliferation in aged mice with EAE pathology by facilitating DNA-PKcs recruitment and phosphorylation of the kinase ZAK. A specific ZAK inhibitor can alleviate EAE pathology in aged mice.

IMMUNITY (2021)

Article Immunology

BFAR coordinates TGFβ signaling to modulate Th9-mediated cancer immunotherapy

Siyu Pei, Mingzhu Huang, Jia Huang, Xiaodong Zhu, Hui Wang, Simona Romano, Xiuyu Deng, Yan Wang, Yixiao Luo, Shumeng Hao, Jing Xu, Tao Yu, Qingchen Zhu, Jia Yuan, Kunwei Shen, Zhiqiang Liu, Guohong Hu, Chao Peng, Qingquan Luo, Zhenzhen Wen, Dongfang Dai, Yichuan Xiao

Summary: The study reveals that down-regulation of BFAR induced by TGFβ is a key mechanism affecting Th9 induction, which in turn impacts Th9-mediated cancer immunotherapy by regulating the activation of TGFβ signaling pathway.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Biochemistry & Molecular Biology

The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability

Qiang Pan, Shanshan Zhong, Hanling Wang, Xuege Wang, Ni Li, Yaqi Li, Guoying Zhang, Huairui Yuan, Yannan Lian, Qilong Chen, Ying Han, Jiacheng Guo, Qiuli Liu, Tong Qiu, Jun Jiang, Qintong Li, Minjia Tan, Huiyong Yin, Junjie Peng, Yichuan Xiao, Jun Qin

Summary: Cholesterol metabolism is closely related to colorectal cancer, but the clinical benefit of statins in inhibiting the mevalonate pathway is uncertain. This study reveals that ZMYND8 plays a crucial role in enhancing de novo cholesterol biosynthesis and promoting the growth of intestinal tumors with high YAP expression.

MOLECULAR CELL (2021)

Article Biochemistry & Molecular Biology

Limb development genes underlie variation in human fingerprint patterns

Jinxi Li, James D. Glover, Haiguo Zhang, Meifang Peng, Jingze Tan, Chandana Basu Mallick, Dan Hou, Yajun Yang, Sijie Wu, Yu Liu, Qianqian Peng, Shijie C. Zheng, Edie Crosse, Alexander Medvinsky, Richard A. Anderson, Helen Brown, Ziyu Yuan, Shen Zhou, Yanqing Xu, John P. Kemp, Yvonne Y. W. Ho, Danuta Z. Loesch, Lizhong Wang, Yingxiang Li, Senwei Tang, Xiaoli Wu, Robin G. Walters, Kuang Lin, Ruogu Meng, Jun Lv, Jonathan M. Chernus, Katherine Neiswanger, Eleanor Feingold, David M. Evans, Sarah E. Medland, Nicholas G. Martin, Seth M. Weinberg, Mary L. Marazita, Gang Chen, Zhengming Chen, Yong Zhou, Michael Cheeseman, Lan Wang, Li Jin, Denis J. Headon, Sijia Wang

Summary: This study conducted genome-wide scans in Han Chinese cohorts and identified 18 loci associated with fingerprint type, as well as a genetic basis for the recognized pattern-block correlations. Additionally, a variant near EVI1 was found to alter regulatory activity and play a role in dermatoglyph patterning. Trans-ethnic meta-analysis identified 43 fingerprint-associated loci and revealed a genetic correlation between fingerprint patterns and hand proportions. These findings highlight the importance of limb development genes in shaping fingerprint patterning.
Article Multidisciplinary Sciences

Golgi stress induces SIRT2 to counteract Shigella infection via defatty-acylation

Miao Wang, Yugang Zhang, Garrison P. Komaniecki, Xuan Lu, Ji Cao, Mingming Zhang, Tao Yu, Dan Hou, Nicole A. Spiegelman, Ming Yang, Ian R. Price, Hening Lin

Summary: This study reveals the role of protein deacetylase SIRT2 in Golgi stress induced by bacterial infection. Shigella secrete effector protein IcsB, which transfers fatty acyl groups to modify host proteins to evade immune surveillance. Upregulated SIRT2 counteracts this function by removing the fatty acyl groups and enhancing the killing of Shigella.

NATURE COMMUNICATIONS (2022)

Article Cell Biology

Targeting UHRF1-SAP30-MXD4 axis for leukemia initiating cell eradication in myeloid leukemia

Cheng-Long Hu, Bing-Yi Chen, Zijuan Li, Tianbiao Yang, Chun-Hui Xu, Ruirui Yang, Peng-Cheng Yu, Jingyao Zhao, Ting Liu, Na Liu, Bin Shan, Qunling Zhang, Junhong Song, Ming-Yue Fei, Li-Juan Zong, Jia-Ying Zhang, Ji-Chuan Wu, Shu-Bei Chen, Yong Wang, Binhe Chang, Dan Hou, Ping Liu, Yilun Jiang, Xiya Li, Xinchi Chen, Chu-Han Deng, Yi-Yi Ren, Roujia Wang, Jiacheng Jin, Kai Xue, Ying Zhang, Meirong Du, Jun Shi, Ling-Yun Wu, Chun-Kang Chang, Shuhong Shen, Zhu Chen, Sai-Juan Chen, Xiaolong Liu, Xiao-Jian Sun, Mingyue Zheng, Lan Wang

Summary: Aberrant expression of UHRF1, an epigenetic regulator, in acute myeloid leukemia (AML) is associated with poor prognosis. UHRF1 is crucial for the self-renewal of leukemia initiation cells (LICs) and its interaction with SAP30 represses gene expression. Inhibition of UHRF1 or SAP30 leads to derepression of MXD4, an MYC antagonist, and suppresses leukemogenesis. Furthermore, a UHRF1 inhibitor, UF146, shows promising therapeutic efficacy in a myeloid leukemia model.

CELL RESEARCH (2022)

暂无数据